Bayer profit flat as weak animal health offsets strong Xarelto

Bayer’s best-selling stroke prevention drug Xarelto contributed to the positive surprise with a better-than-expected 933 million euros in quarterly sales, helped by a wider range of health conditions for which the pill can be prescribed.

Original source: https://health.economictimes.indiatimes.com/news/pharma/bayer-profit-flat-as-weak-animal-health-offsets-strong-xarelto/66604263?utm_source=RSS&utm_medium=ETRSS